Subcutaneous epcoritamab with R-CHOP in previously untreated high-risk diffuse large B-cell lymphoma, including double-hit/triple-hit lymphoma: Updated results from EPCORE NHL-2 Meeting Abstract


Authors: Falchi, L.; Clausen, M. R.; Offner, F.; de Vos, S.; Brody, J. D.; Kim, M. L.; Snauwaert, S.; Cordoba, R.; Oki, T.; Bykhovski, I.; Wang, L.; Rana, A.; Belada, D.
Abstract Title: Subcutaneous epcoritamab with R-CHOP in previously untreated high-risk diffuse large B-cell lymphoma, including double-hit/triple-hit lymphoma: Updated results from EPCORE NHL-2
Meeting Title: 2023 Lymphoma, Leukemia and Myeloma Congress
Journal Title: American Journal of Hematology
Volume: 98
Issue: Suppl. 5
Meeting Dates: 2023 Oct 18-21
Meeting Location: New York, NY
ISSN: 0361-8609
Publisher: John Wiley & Sons, Inc.  
Date Published: 2023-10-01
Start Page: S50
Language: English
ACCESSION: WOS:001098086400080
PROVIDER: wos
DOI: 10.1002/ajh.27112
Notes: Meeting Abstract: P-079 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lorenzo Falchi
    107 Falchi